Retraction Note: RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo.

Ping Huang,Guohui Cui,Xiaozheng Liu,Jun Wu,Ximeng Li,Yinghuan Li

doi:10.1007/s11095-016-1866-8

Retraction Note: RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo.

Ping Huang, Guohui Cui + Show 4 more

Open Access

https://doi.org/10.1007/s11095-016-1866-8

Copy DOI

Journal: Pharmaceutical research

Publication Date: Feb 2, 2016

Affiliation: Capital Medical University, University of South Carolina

#Poly L-lactic Acid Nanoparticles #Loaded Poly L-lactic Acid + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Purpose A novel hydrophilic conjugate of arginine-glycine-aspartic acid (RGD) and polyethylene glycol (PEG), i.e., RGD-PEGMw (MW = 300, 600, 1000 or 4000), was synthesized and employed in epirubicin (EPI) loaded poly L-lactic acid (PLLA) nanoparticles (NPs) to improve its tumor targeting effect.

Full Text